NCT06772597Phase 2Active not recruiting

A Study of Setmelanotide in Patients With Prader-Willi Syndrome

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-10-31Estimated

Enrollment · participants18Actual

Source updated2026-02-12Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-12 · 3 fields changed

Participant count type changed

− Before

~~Estimated~~

+ After

Actual

Enrollment · participant count changed

− Before

~~20 participants (planned)~~

+ After

18 participants (actual)

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source

Posted 2025-10-15 · 1 field changed

Primary completion date changed

− Before

~~31 Jan 2026~~

+ After

31 Oct 2026

Check registry source